Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThermoProfen long-term safety in knee osteoarthritis
NCT00532038Phase 3Terminated
- Sponsor
- ZARS Pharmaceuticals
- Start
- Sep 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ThermoProfen in osteoarthritis (OA), sponsored by ZARS Pharmaceuticals. Primary endpoint: Safety of long-term administration up to 12 months. Started Sep 2007; status: terminated.
02
Drugs
ThermoProfen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00532038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532038.